Holobiome Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $10M

  • Investors
  • 26

Holobiome General Information

Description

Developer of a biotechnology platform designed to discover and develop therapies from the human microbiome. The company's platform offers research-driven microbiome analysis to identify beneficial and harmful microbial strains, probiotic formulation to create customized supplements and therapeutic products, and targeted health interventions to support gut health, metabolic balance, and immune system function, enabling healthcare professionals and patients to improve whole-body health and address complex medical challenges.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 650 Albany Street
  • Boston, MA 02118
  • United States
+1 (857)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 650 Albany Street
  • Boston, MA 02118
  • United States
+1 (857)

Holobiome Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Holobiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Later Stage VC 22-Jul-2026 $10M Completed Generating Revenue
19. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
18. Seed Round 09-Oct-2024 Completed Generating Revenue
17. Accelerator/Incubator Completed Generating Revenue
16. Accelerator/Incubator 04-Mar-2024 Completed Generating Revenue
15. Grant 28-Oct-2021 Completed Generating Revenue
14. Grant 24-Sep-2021 Completed Generating Revenue
13. Grant 24-Sep-2021 Completed Generating Revenue
12. Seed Round 11-Feb-2021 $825K $2.11M Completed Generating Revenue
11. Grant 01-Nov-2020 $500K $1.28M Completed Generating Revenue
To view Holobiome’s complete valuation and funding history, request access »

Holobiome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed-2
Seed-3 488,402 $0.000100 $1.91 $1.91 1x $1.91 3.64%
Seed-4 927,913 $0.000100 $1.43 $1.43 1x $1.43 6.92%
To view Holobiome’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Holobiome Patents

Holobiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026055454-A1 Inactivated bacteroides bacteria and methods of use thereof Pending 05-Sep-2024
WO-2025184340-A1 Prebiotic combinations Pending 27-Feb-2024
AU-2020308897-A1 Therapeutic compositions and methods of using serotonin modulating microbiome-based interventions to treat serotonin-related diseases or disorders Pending 27-Jun-2019
CA-3144072-A1 Therapeutic compositions and methods of using serotonin modulating microbiome-based interventions to treat serotonin-related diseases or disorders Pending 27-Jun-2019
EP-3989992-A2 Therapeutic compositions and methods of using serotonin modulating microbiome-based interventions to treat serotonin-related diseases or disorders Pending 27-Jun-2019 A61K35/745
To view Holobiome’s complete patent history, request access »

Holobiome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Holobiome Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plug and Play Accelerator/Incubator
Able Partners Venture Capital Minority
Astanor Impact Investing Minority
Bantam Group Angel Group Minority
Bluebirds Capital Venture Capital Minority
You’re viewing 5 of 26 investors. Get the full list »

Holobiome Acquisitions (1)

Holobiome’s most recent deal was a Merger/Acquisition with AsiaBiome. The deal was made on 01-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AsiaBiome 01-Sep-2022 Merger/Acquisition Drug Discovery
To view Holobiome’s complete acquisitions history, request access »

Holobiome FAQs

  • When was Holobiome founded?

    Holobiome was founded in 2015.

  • Where is Holobiome headquartered?

    Holobiome is headquartered in Boston, MA.

  • What is the size of Holobiome?

    Holobiome has 20 total employees.

  • What industry is Holobiome in?

    Holobiome’s primary industry is Drug Discovery.

  • Is Holobiome a private or public company?

    Holobiome is a Private company.

  • What is Holobiome’s current revenue?

    The current revenue for Holobiome is .

  • How much funding has Holobiome raised over time?

    Holobiome has raised $11.2M.

  • Who are Holobiome’s investors?

    Plug and Play, Able Partners, Astanor, Bantam Group, and Bluebirds Capital are 5 of 26 investors who have invested in Holobiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process